Registry study of outcomes from Mayo radiation treatments
Part of Blood & lymphatic, Cancer clinical trials.
This study collects information about how patients do after radiation treatment and stores some biological samples for future research. It includes people treated at Mayo Clinic Rochester for a cancer-focused (curative) course of radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received radiation treatment at Mayo Clinic Rochester in the Radiation Oncology department
- Your treatment used photon or proton radiation
- The radiation was given with the goal to cure the cancer (curative intent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how doctors' behavior affects the distress cancer patients feel. It's for patients who are getting or recently finished radiation at Mayo Clinic in Rochester.
This registry study collects information from people who are planning to receive radiation therapy. The goal is to better understand treatment outcomes and help improve radiation care over time.
This trial collects health and lab information from adults treated with metabolic radiotherapy in the nuclear medicine department. It may help doctors better understand how these treatments work for thyroid cancer, neuroendocrine tumors, or prostate cancer.
This study tests a new computer tool that helps doctors accurately outline healthy organs during radiation planning. It is for Mayo Clinic staff who already do this work.
This study keeps a secure record of people receiving proton therapy to track outcomes over time. It may help researchers understand how proton therapy works in real life and improve future care.
This study follows people with cancer to better understand which treatments cause certain side effects when radiation is combined with targeted (molecular) medicines. Your participation may help doctors predict and manage side effects more safely in the future.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.